Weili Luo
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and Cardiovascular Safety of Pegmolesatide in Patients with Anemia of Chronic Kidney Disease: Post hoc Analysis of Two Phase 3 Randomized Trials.
Journal: Kidney diseases (Basel, Switzerland)
Published: November 12, 2025
Correction: Overview of preclinical and phase II clinical studies on Pegmolesatide's long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction.
Journal: Journal of translational medicine
Published: June 03, 2025
Overview of preclinical and phase II clinical studies on Pegmolesatide's long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction.
Journal: Journal of translational medicine
Published: November 20, 2024
Wnt/β-Catenin Signaling Mediated-UCH-L1 Expression in Podocytes of Diabetic Nephropathy.
Journal: International journal of molecular sciences
Published: July 08, 2016
Role of miR‑21 on vascular endothelial cells in the protective effect of renal delayed ischemic preconditioning.
Journal: Molecular medicine reports
Published: January 19, 2016
NF-κB upregulates ubiquitin C-terminal hydrolase 1 in diseased podocytes in glomerulonephritis.
Journal: Molecular medicine reports
Published: July 23, 2014
The regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes.
Journal: Cellular signalling
Published: February 26, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026